Back to search

Article

Tackling the Inverse Care Law with pharmacist-led cardio-renal-metabolic service in a socioeconomically deprived population: A prospective scoping intervention study

2025-03-20

Abstract excerpt

<title>Abstract</title> <p>Background Chronic kidney disease (CKD) is a leading cause of premature mortality, often coexisting with cardiovascular disease and diabetes mellitus; disproportionately affecting socioeconomically deprived groups. CKD is projected to increase due to ageing, obesity and diabetes. General practice clinical pharmacists (GPCPs) have been shown to be effective in challenging chronic diseas...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ef34320c-fec3-56c3-8eec-ca8411c9eba1
DOI
10.21203/rs.3.rs-6209460/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Tackling the Inverse Care Law with pharmacist-led cardio-renal-metabolic service in a socioeconomically deprived population: A prospective scoping intervention studyDOI 10.21203/rs.3.rs-6209460/v1
APOSCREEN-1 – a prospective implementation study for pharmacy-based screening for cardiovascular-kidney-metabolic risk factors in Schleswig-HolsteinSemantic proximity
Estimating the population-level kidney benefits of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease in Australian primary careSemantic proximity
Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618,161 people in primary careSemantic proximity
Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in the Very Elderly with Chronic Kidney Disease: a Retrospective Cohort Study Using Real-World DataSemantic proximity
Exploring the implementation and integration of structured medication reviews in primary care: A qualitative evaluation using normalization process theorySemantic proximity
Use of drugs with Pharmacogenomics (PGx)-Based Dosing Guidelines in a Danish Cohort of Persons with Chronic Kidney Disease, Both on Dialysis and Not on Dialysis: Perspectives for Prescribing OptimizationSemantic proximity
The prevalence of chronic kidney disease in Australian primary care: analysis of a national general practice datasetSemantic proximity
Predicting and Validating Risk of Pre-Pandemic and Excess Mortality in Individuals With Chronic Kidney DiseaseSemantic proximity
Cardiorenal outcomes of tirzepatide versus semaglutide in adults with type 2 diabetes and chronic kidney disease: a target trial emulation in the TriNetX Global Collaborative NetworkSemantic proximity
Optimizing Prescribing in Older Adults with Multimorbidity and Polypharmacy in Primary Care: A Cluster Randomized Clinical Trial (OPTICA Trial)Semantic proximity
Does it matter how we define chronic kidney disease in primary care? Insights from the observational ATLAS studySemantic proximity
Optimising Prescription of Treatment In older patients with Mild hypertension at Increased risk of Serious adverse Events (OPTIMISE2): Protocol for a primary care based, open-label, randomised controlled non-inferiority trialSemantic proximity
Select a neighboring publication to make it the new centre.